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41 Amino acid long N-terminal sequences of the three major human vitamin D-binding proteins (group- 
specific components Gel F, GclS and Gc2) were characterized: they were identical. By computer analyses, 
the alignment of this N-terminal sequence with several sequences of human serum pre-proalbumin and hu- 
man pre-a-fetoprotein was established 
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1. INTRODUCTIOT - 
Discovered by Hirschfeld in 1959 [1], group- 
specific component (Gc) is a protein present in 
human plasma at a concentration of 
20-50 mg/lOO ml [2]. Recent interest comes from 
the observation that its biological role is the 
transport of vitamin D metabolites in plasma [3]. 
In addition, tissue actin binds Gc protein with high 
affinity [4,5] and the latter is involved in the 
linkage between membrane immunoglobulin (MIg) 
of B lymphocytes and actin [61. 
Cc protein is highly polymorphic and at the pre- 
sent time a total of 84 different Gc alleles have 
been identified [7]. Nevertheless, only 3 major Cc 
alleles (GclF, GclS and Gc’) have been detected in 
most of the populations studied so far. 
Previously, the first 20 amino acid residues of 
the 3 major group-specific components GclF, 
GclS and Gc2 have been reported: their N- 
terminal sequences were identical [8]. In this note 
we report the extension of these N-terminal se- 
quences (residues 1+41) and by computer analyses 
we demonstrate for the first time a structural 
homology between Gc proteins, human serum 
albumin and human a-fetoprotein. 
2. MATERIALS AND METHODS 
2.1. Materials 
Human Gc proteins (GclF, GclS, Gc2) were 
purified from plasma fractions of individual 
homozygotes according to the procedure of Viau et 
al. [9]. All reagents (analytical grade) were pur- 
chased from Prolabo or Merck except those 
employed for the sequencer which were obtained 
from Pierce or SDS (Marseilles). 
2.2. Methods 
The 3 major Gc proteins were reduced with 
2-mercaptoethanol [lo] and alkylated with 
iodoacetamide [ 111. Automated Edman degrada- 
tion was carried out in a Beckman Sequencer 
890 C by the 1 M quadrol method in the presence 
of polybrene [ 121; the phenylthiohydantoin amino 
acids were identified by high-performance liquid 
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chromatography with a Waters chromatograph 
(model ALC/GPC 204) [ 131. 
The search of sequences homologous to the N- 
terminal sequence of Gc proteins was performed 
according to the program SEARCH. The sequence 
data base of the Atlas of Protein Sequence and 
Structure updated to August 1984 as well as the 
program SEARCH were provided by the National 
Biomedical Research Foundation. Amino acid se- 
quences were compared using the proportional 
matching option of the interactive graphics pro- 
gram DIAGON [14]. The latter incorporates a 
scoring system based on the MDM7s matrix, which 
was calculated from accepted point mutations of 
71 families of related proteins [15]. Thus, se- 
quences which are related in the proteins under 
comparison appear as diagonal lines on the 
graphical output. To obtain the alignment of two 
homologous sequences the program of Smith and 
Waterman [16] was applied. 
albumin of different species [21-241. To show a 
possible alignment between the N-terminal se- 
quence of Gc proteins and human Lu-fetoprotein, 
we performed a second series of computer tests us- 
ing the program DIAGON [14] and the method of 
Smith and Waterman [ 161. We obtained the align- 
ment of our N-terminal sequence with several se- 
quences of human pre-proalbumin (pre-proHSA) 
[17] as well as with human prep-fetoprotein (pre- 
AFP) [21]. We report in fig.1 the structural rela- 
tionship observed between the N-terminal se- 
quence of Gc proteins and two sequences of pre- 
proHSA (residues 20+60 and 404-+444) and one 
sequence of pre-AFP (residues 404+444). For 
these 3 alignments the sequence homology (iden- 
tical and homologous residues in corresponding 
positions) is 34%. 
3. RESULTS AND DISCUSSION 
The 41 amino acid long N-terminal sequences of 
reduced and alkylated GclF, GclS and Gc2 pro- 
teins were automaticaiiy established (fig.1): they 
were identical. Two differences (GlufGln and 
Asp/Asn, in positions 2 and 6, respectively) were, 
however, noted between our sequence and the 
shorter (l-+20 residues) previously proposed [S]. 
Based on our new sequence data we performed a 
first series of computer analyses (program 
SEARCH): they pointed out similarity between the 
N-terminal sequence of Gc proteins and human, 
bovine and rat pre-proalbumins (sequence data in 
[ 17-201). 
In addition a clear demonstration of these se- 
quence homologies is shown in fig.2a-c by the 
diagonal plot method of Staden [14]. Taking into 
account the strong relatedness between serum 
albumin and cu-fetoprotein and the localization of 
their disulfide bridges, these two proteins could be 
subdivided into 3 similar repeat units called do- 
mains (I-III) [19,21-241. The N-terminal Gc se- 
quence corresponds to the propeptide of pre- 
proHSA lengthened by the beginning of domain I 
of HSA. Similarly, our sequence is aligned with the 
homologous sequences of pre-proHSA and pre- 
AFP (residues 404+444) which surround the 
beginning of domain III of each protein [21]. In a 
previous study, a computer search including only 
the 20 first amino-terminal residues of Gc proteins 
(program SEARCH) failed to show similarity with 
any reported sequence [8]. Indeed, the maximum 
homology is situated only after residue number 20. 
Previously, structural homology was clearly Recently an immunological cross-reactivity was 
demonstrated between tr-fetoprotein and serum demonstrated between Gc protein and human 
GclF, IS, 2 
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Fig. 1. The N-terminal sequence of Gc proteins (residues 1 -41): comparison with human pre-proalbumin (pre-proHSA) 
[17] and human pre-cu-fetoprotein (pre-AFP) [21]. The alignment was determined according to the program of Smith 
and Waterman [16]. Boxed areas correspond to residues identical or homologous to the Cc protein sequence (0). The 
one-letter amino acid abbreviation system is used. Arrows (1) indicate the beginning of domains I and III of human 
serum albumin and cu-fetoprotein according to [21]. 
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Fig.2. Diagonal plot of the N-terminal sequence of Gc proteins (residues 1 -+41) against human pre-proalbumin We- 
z 
proHSA) [17] and human pre-cu-fetoprotein (pre-AFP) [21] according to the program DIAGON [14]. The homology 
is shown by the strong diagonal clustering of points (arrow +). (a) Diagonal plot against pre-proHSA (residues l-60). 
(b) Diagonal plot against pre-proWSA (residues 390-+450). (c) Diagonal plot against pre-AFP (residues 390+450). 
49 
Volume 185, number 1 FEBS LETTERS June 1985 
serum albumin and human cu-fetoprotein, sug- 
gesting that these 3 proteins have evolved from the 
same ancestral protein [ZS]. Our structurai 
molecular studies reported here seem to cor- 
roborate this hypothesis. 
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